The FDA Criteria For Going After Pharma Executives
21 CommentsBy Ed Silverman // February 8th, 2011 // 8:08 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Jan | Mar » | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | |||||
• Pharma Blog » 2011
Pharmalot February, 2011 Archive
Most Docs Support Avastin Restriction: Survey
1 CommentBy Ed Silverman // February 7th, 2011 // 12:17 pm
EU Trade Deal Could Cost Canada $3B For Drugs
4 CommentsBy Ed Silverman // February 7th, 2011 // 11:24 am
Pfizer, Tax Incentives And Jobs: Worth The Price?
2 CommentsBy Ed Silverman // February 7th, 2011 // 10:28 am
Abbott Labs, Breastfeeding & A Baby Formula Survey
3 CommentsBy Ed Silverman // February 7th, 2011 // 9:29 am
Lilly Ties Employee Bonus To R&D Pipeline
1 CommentBy Ed Silverman // February 7th, 2011 // 8:28 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // February 7th, 2011 // 7:54 am
Should The FDA Review Drugs Used For Executions?
17 CommentsBy Ed Silverman // February 4th, 2011 // 10:06 am
Merck, Groundwater Pollution & Sick Neighbors
3 CommentsBy Ed Silverman // February 4th, 2011 // 8:57 am